Treatment with Vyndaqel (tafamidis) or liver transplant can significantly improve the long-term outcome of patients with familial…
Alice Melao
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melao
Researchers reported a rare case of familial amyloid polyneuropathy (FAP) in a patient with TRR gene Val30Met mutation who…
Blood vessel abnormalities in the eye’s structures are common features in patients with familial amyloid polyneuropathy (FAP) caused by…
Vyndaqel (tafamidis) failed to prevent the progressive accumulation of abnormal transthyretin protein in a patient with a rare variant of…
Familial amyloid polyneuropathy (FAP) is linked to important alterations of the autonomic nervous system, which regulates certain body processes…
Ionis Pharmaceuticals’ inotersen (IONIS-TTR Rx) continues to demonstrate sustained, long-term benefit for patients with familial amyloid polyneuropathy (FAP),…
Researchers suggest that guidelines and standardized protocols are needed to evaluate the autonomic nervous system — which regulates certain body…
Researchers have found that imaging contrast agent MIBG can help detect early nerve cell damage affecting the heart before serious…
Changes in the way that people with a certain gene mutation walk could help doctors make an early determination that they have…
The artificial induction of joint ossification, or surgical arthrodesis, is a safe and effective option to treat patients with…